Sector analysis: Health & life sciences

Global Corporate Venturing ran a short survey of corporate venture capital investors on the impact of the Covid-19 pandemic in April.

Global Corporate Venturing hosted its first virtual conference, GCV Digital Forum, on June 3 and 4 with a special networking space and ideas challenge.

One of the oldest universities in the world has been spinning out companies with remarkable success for more than half a century

Think about the features you would expect to find at a GCV event… then imagine them all in a virtual setting.

Monthly analysis: April 2020

Quarterly data report: Q1 2020

Monthly data report: March 2020

What do you do after you have launched a spinout that has raised venture capital from illustrious backers such as pharmaceutical firm Novo, care provider Kaiser Permanente and medical device manufacturer St Jude Medical, and successfully gone public through a $107m initial public offering?

A host of corporate and government-backed initiatives have been launched to tackle the coronavirus that develops into the Covid-19 disease. In a global, fast-moving pandemic, this can only be a snapshot of the efforts at the end of March 2020.